chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen lymph nodes on my neck it is sweeling up/lymph nodes in the left side of her neck are swollen; The lymph nodes in the left side of her neck are swollen and it is very painful; Bad dizziness/she felt dizzy/dizzy for 3 about days; Weakness/ weak for 3 about days; One hour after the shot both arms and legs very numb and rigid; One hour after the shot both arms and legs very numb and rigid, this lasted for about 2 days; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Bad dizziness/she felt dizzy/dizzy for 3 about days), ASTHENIA (Weakness/ weak for 3 about days), HYPOAESTHESIA (One hour after the shot both arms and legs very numb and rigid), MUSCLE RIGIDITY (One hour after the shot both arms and legs very numb and rigid, this lasted for about 2 days) and LYMPHADENOPATHY (Swollen lymph nodes on my neck it is sweeling up/lymph nodes in the left side of her neck are swollen) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2021, the patient experienced DIZZINESS (Bad dizziness/she felt dizzy/dizzy for 3 about days), ASTHENIA (Weakness/ weak for 3 about days), HYPOAESTHESIA (One hour after the shot both arms and legs very numb and rigid) and MUSCLE RIGIDITY (One hour after the shot both arms and legs very numb and rigid, this lasted for about 2 days). On 19-Aug-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes on my neck it is sweeling up/lymph nodes in the left side of her neck are swollen) and LYMPH NODE PAIN (The lymph nodes in the left side of her neck are swollen and it is very painful). At the time of the report, DIZZINESS (Bad dizziness/she felt dizzy/dizzy for 3 about days), ASTHENIA (Weakness/ weak for 3 about days), HYPOAESTHESIA (One hour after the shot both arms and legs very numb and rigid) and MUSCLE RIGIDITY (One hour after the shot both arms and legs very numb and rigid, this lasted for about 2 days) had resolved and LYMPHADENOPATHY (Swollen lymph nodes on my neck it is sweeling up/lymph nodes in the left side of her neck are swollen) and LYMPH NODE PAIN (The lymph nodes in the left side of her neck are swollen and it is very painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Aug-2021: Follow up document received on 19 Aug 2021 included reporter address, patient details and new events were added. Dose details and events onset date were  updated.
Change in behavior (inappropriate laughing, maturity regression), hair loss.  Reported to us 10-21-08.  Status changes were noted approximately 2 weeks after vaccine administration.
My nose was full of green, yellow mucous coming out. I had a little body ache, a little fatigue, and a cough. No appetite. I did not have a fever, but I felt feverish. On 4/11/2023, I called my doctor, he prescribed Amoxicillin and cough medicine, Treason Perles. The doctor said if I was not better by Friday to call him back. I was greatly improved by Friday.
Bleeds under her skin from knees to ankles; Left ankle is swollen; A spontaneous report was received from a consumer concerning a 76-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced bleeds under her skin from knees to ankles, left ankle is swollen.  The patient's medical history, as provided by the reporter, included, 21 years ago the patient had a virus that attacked her spleen, she does not have her spleen. She stated that two weeks before the Moderna shot she got two hips injections. Additional suspected medications included: on 29-Jan-021, two knee injections.  On 26-Jan-2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 039K20A) intramuscularly for prophylaxis of COVID-19 infection.  On 13-Feb -021, the patient experienced bleeds under her skin in both legs from knees to ankles, her left ankle was swollen. She stated that the bleed spots started like little dots. She would get blood work done.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of events, bleeds under her skin from knees to ankles, left ankle is swollen was unknown.; Reporter's Comments: This patients petechial rash is likely due to the knee injections and unlikely to be due to Moderna Covid 19 vaccine. However, based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
A nurse called in to report an adverse event for 7 patients who received an expired dose of the Moderna COVID-19 vaccine/ Expiration: 06DEC2021 and administered on 08DEC2021; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A nurse called in to report an adverse event for 7 patients who received an expired dose of the Moderna COVID-19 vaccine/ Expiration: 06DEC2021 and administered on 08DEC2021) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A, 033621A and 044B21A) for COVID-19 vaccination.     Concomitant products included HYDROXYCHLOROQUINE, HYDROCORTISONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE), IBUPROFEN and OMEPRAZOLE for an unknown indication.   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (A nurse called in to report an adverse event for 7 patients who received an expired dose of the Moderna COVID-19 vaccine/ Expiration: 06DEC2021 and administered on 08DEC2021). On 08-Dec-2021, EXPIRED PRODUCT ADMINISTERED (A nurse called in to report an adverse event for 7 patients who received an expired dose of the Moderna COVID-19 vaccine/ Expiration: 06DEC2021 and administered on 08DEC2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication was reported.  The vial was initially stored in the refrigerator on 08-Dec-2021, later taken out of freezer and placed into the fridge again. The vial did not undergo any temperature excursions.   This case was linked to MOD-2021-408598 (Patient Link).
Pain around injection site within 10 hrs. Redness around injection sight (3" diameter) within 24 hrs. Headache, tired feeling within 18 hrs, Slight fever within 24 hrs. Belly pain, upset stomach within 24 hrs.
2JUN95 area of erythema on lt deltoid area; fainted red, really warm or tender, 4" diameter; no h/a or nausea, no fever, not scratching it;
day 1 post vaccination: pt reported bruising at injection site; days 2-3 post vaccination: pt report redness below injection site and warm to touch, and soreness. muscle tenderness as well at site; pt appears to be ok with breathing. pt came down to pharmacy to show injection site and visually red at sight
1 of 2 pts devel a local react; pt had an inject site react from lt deltoid to elbow, warm & erythematous; dx cellulitis, was started on ATB;
APPROXIMATELY TWO WEEKS AFTER MY SHOT I BEGAN TO BECOME ITCHY ON THE BACK OF MY HEAD AND NECK, THEN AFTER A FEW MORE DAYS I STARTED TO GET BUMPS AND ITCHYNESS ON THE BACK OF MY ELBOWS , KNEES, AND AROUND MY WAISTLINE AREA.
per patient noted Left upper arm swollen, Red and tender to touch. Noted Wednesday AM. Temperature x 2 nights-Monday and Tuesday up to 101 deg
Nauseous, lower body ache, low grade fever.  Very Nauseous at 48hrs.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 21-JUN-2012, the patient was administered with a dose of VARIVAX (merck) (Lot # 1909AA, expiry date unknown) (Route, dosing regimen and frequency unknown) which was exposed to a temperature excursion of up to -3 degrees Centigrade. No adverse events were reported. No product quality issue was reported. This is one of the many reports received from the same source. Additional information has been requested.
This spontaneous case, initially received on 02-Nov-2016, was reported by a health professional and concerns a 67 year old patient. Weight: not provided; Height: not provided. Concomitant medication: Not reported. Administration of company suspect drug(s): On 16-Sep-2016 the patient received AFLURIA. Dose regimen: Not reported, Route of administration: Intramuscular. Batch number: WT54306. No additional suspect drugs. Adverse event description: On 23-Sep-2016, a nurse reported that a refrigerator went in and out of (temperature) range while there was flu vaccine in it. On 16-Sep-2016, doses were administered (special circumstances: drug administration error without adverse event, incorrect product storage without adverse event). Flu vaccine was first delivered to the vaccination facility on 15-Aug-2016. As the nurse reviewed the refrigerator temperature log, she stated that another excursion occurred on 15-Sep-2016. The doses arrived at 09:00 and were placed in a refrigerator that was at 10 degrees Celsius in the morning. Then the temperature remained at 9 degrees Celsius throughout the 15th and 51 doses were administered on the 16th at a flu clinic. The refrigerator was not back in range until 19-Sep-2016 at a temperature of 8 degrees Celsius. Temperature excursion identified: Log documentation reflected temperature excursions from 31-May-2016 to 23-Sep-2016 which ranged between 8 to 10 degrees Celsius. Vaccines had been given to patients between 31-May-2016 and 23-Sep-2016. On 04-Oct-2016, the remaining 42 doses of lot number WT54306 were discarded. The patients will be contacted for revaccination.
Complaints of swelling, pain, and redness right upper arm since last evening. Upon exam, significant swelling, warmth, and redness is noted. Examined on 12/22. Arm appears normal.
1. Extremely heavy periods since vaccination resulting in being able to soak a super tampon and a 10-hour pad in a couple of hours and also soil underwear.  This has happened more than once. 2. I also have a previous history of heart arrhythmia (SVT and AVNRT) that was treated in 2018 and well managed since then until two weeks after vaccination when the arrhythmia returned and I am now being treated for re-emergence of the problems with my EP doctor.
Pt stated about 1-2 months ago she started to notice a sharp pain in her upper arm but can't remember exactly when. The vaccine was given about 3 months ago and she feels it is the cause. It is a sharp pain that only occurs typically at bedtime and sometimes only lasts about a few minutes and sometimes longer 10-15 minutes and it occurs randomly.
injection site is red; injection site is swollen; arm began to itch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (arm began to itch), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (arm began to itch). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen). At the time of the report, VACCINATION SITE PRURITUS (arm began to itch), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient did not receive any treatment medications.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
received dose from vial refrigerated more than 30 days; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (received dose from vial refrigerated more than 30 days) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Sep-2021 at 2:49 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021 at 2:49 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT STORAGE ERROR (received dose from vial refrigerated more than 30 days). On 15-Sep-2021 at 2:49 PM, PRODUCT STORAGE ERROR (received dose from vial refrigerated more than 30 days) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided. No treatment medication provided.   This case was linked to MOD-2021-322337, MOD-2021-322483 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Nov-2021: Follow-up received contains added patient DOB and initials.
Pt became nauseaus around 7:00p on 9/18/18 and had a lighter than normal dinner because she was not hungry. Around 9pm she began feeling more tired than normal and had difficulty falling asleep because she felt uncomfortable. Around midnight she began experiencing full body aches and joint pain followed by shivering/shaking around 2am. She slept all morning and felt better around 1pm 9/19/18. She did take ibuprofen 200mg 1 tablet at 2am 9/18/18, 8am 9/19/18 and 1pm 9/19/18. Pt did not see a physician.
Deep red Flush Began in cheeks And spread down to jaw line; This is a spontaneous report from a contactable consumer (patient).  A 75-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), via an unspecified route of administration at Left arm on 25Jan2021 09:15 at SINGLE DOSE for COVID-19 immunization. Medical history included Penicillin allergy, no other medical history. Concomitant medication included simvastatin. The patient was not pregnant. The patient developed a deep red flush that started in her cheeks and went down to her jaw line on 25Jan2021 on 14:00. Stated that flush seemed to be abating but if it came back and/or other reactions occur she could go to Emergency Room. She had electrical shocks going down her left side. Stated that she read through everything on fact sheet but did not see that a flush might occur, it had been 8 hours. This was her first shot, had an appointment for three weeks for her second shot. No COVID prior to vaccination, no COVID tested post vaccination. The outcome of the event was recovering.
FALL TWICE; BLACK EYE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included rare form of msa parkinson, latex allergy, penicillin allergy, and passes out.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced black eye. On 25-MAR-2021, the subject experienced fall twice. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fall twice and black eye was not reported. This report was non-serious. This case, from the same reporter.
no adverse effect; patient received a dose of PROQUAD via the intramuscular route in error; This spontaneous report was received from a nurse practitioner, referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant therapies, concurrent conditions, previous drug reactions and allergies were not reported.     On 29-OCT-2019, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) as prophylaxis. The dose was administered via intramuscular route (incorrect route of product administration), by error (strength, dose number and frequency were not provided; lot number S017240 and expiration date 01-DEC-2020). No adverse effects were reported.
Yes, so I got the Pfizer booster; Underneath my arm and my armpit was sore; its very swollen like in the lymph nodes; its only in one side of my arm or one arm that I got the shot in; Underneath my arm and my armpit was sore; its only in one side of my arm or one arm that I got the shot in; Underneath my arm and my armpit was sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 09Dec2021 (Lot number: FD0809) as dose 3 (booster) , single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:1), for Covid-19 Immunization; Bnt162b2 (Dose:2), for Covid-19 Immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Yes, so I got the Pfizer booster"; LYMPHADENOPATHY (non-serious) with onset 11Dec2021, outcome "unknown", described as "Underneath my arm and my armpit was sore; its very swollen like in the lymph nodes; its only in one side of my arm or one arm that I got the shot in"; PAIN IN EXTREMITY (non-serious) with onset 11Dec2021, outcome "unknown", described as "Underneath my arm and my armpit was sore; its only in one side of my arm or one arm that I got the shot in"; AXILLARY PAIN (non-serious) with onset 11Dec2021, outcome "unknown", described as "Underneath my arm and my armpit was sore".  Additional information: The patient got the Pfizer booster on the 09Dec2021 and the day before reporting on 11Dec2021 the patient woke up and underneath patient's arm and armpit was sore and so, the following morning on 12Dec2021 which was on the day of reporting morning the patient woke up and its very swollen like in the lymph nodes the patient mentioned. So, the patient was assuming this was a side effect because its only in one side of my arm or one arm that I got the shot in. So, the patient was wondering what should be the next course of action.  No follow-up attempts are possible. No further information is expected.
50 Cent piece sized area under area where Varivax was given, left deltoid - 5/7/07. May be reaction to circular bandaid - which was removed. This all reported by school nurse via PC today. Denies pain, ice pack applied to area.
problems sleeping at night because of the itching; uncomfortable; feel like something still isn't right; itching; rashes all over my body; muscle aches; This spontaneous case was reported by a patient and describes the occurrence of INSOMNIA (problems sleeping at night because of the itching), DISCOMFORT (uncomfortable), FEELING ABNORMAL (feel like something still isn't right), PRURITUS (itching) and RASH (rashes all over my body) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced INSOMNIA (problems sleeping at night because of the itching), DISCOMFORT (uncomfortable), FEELING ABNORMAL (feel like something still isn't right), PRURITUS (itching), RASH (rashes all over my body) and MYALGIA (muscle aches). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) at an unspecified dose and frequency. At the time of the report, INSOMNIA (problems sleeping at night because of the itching), DISCOMFORT (uncomfortable), FEELING ABNORMAL (feel like something still isn't right), PRURITUS (itching), RASH (rashes all over my body) and MYALGIA (muscle aches) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   no concomitant drug were used. Benadryl, Nyquil,steroids were used. steroids were not coded
Two weeks after the shot I had significant blood in my stool which lasted for 5 wks. Every day.
Redness, heat, and some swelling around the injection site. Also reports of tenderness.
Patient presented to emergency department on 8/26/2021 with cough and shortness of breath that started 5 days prior. He tested positive for COVID-19 at an outside facility on 8/23/2021. He was admitted for further management. He required additional oxygen supplementation about his baseline of 3L. He was also treated with remdesivir and decadron. Patient's symptoms improved and was discharged home on 8/30/2021.
Information has been received from a physician concerning a 14 year old female patient who on an unknown date was vaccinated with the 2nd dose of GARDASIL (dose and lot # not provided). On 05-JUN-2012, the patient experienced flu like symptoms after her 2nd dose of GARDASIL. No treatment was given for the event. At the time of the report, the patient's outcome was unknown. The patient did not seek medical attention. Follow up information as received from a health professional refers to a 14 years old female patient with no preexisting allergies, birth defects, medical conditions or illness at the time of vaccination. The patient was vaccinated in the left deltoid with lot # (672193/1524AA) dose 2 GARDASIL on 05-JUN-2012 at 11:00 am (route not reported). No other co-suspects were reported. No concomitant medications were reported. On 05-JUN-2012 at 15:00 the patient experienced flu like symptoms. She couldn't go to practice at 18:00 nor throughout the night. The patient complained of visual disturbance, lower half black on one eye. The patient had a headache for 1 week. No treatment information was reported. The patient never went to the doctor. No laboratory diagnostic studies were performed. The outcome of visual disturbance, half black on one eye, headache and flu like symptoms was unknown. The relatedness for flu like symptoms, headache and visual disturbance, half back on one eye was unknown for GARDASIL. Additional information has been requested.